Lineage Cell Therapeutics, Inc. Proceeds from Grantors
Lineage Cell Therapeutics, Inc. (LCTX) reported Proceeds from Grantors of $261.78 thousand for the 3-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromGrantors · last filed 2013-03-18
- Lineage Cell Therapeutics, Inc. proceeds from grantors for the quarter ending 2012-12-31 was $261.78K.
- Lineage Cell Therapeutics, Inc. proceeds from grantors for the quarter ending 2012-06-30 was $392.67K, a 0.00% change year-over-year.
- Lineage Cell Therapeutics, Inc. proceeds from grantors for the quarter ending 2011-06-30 was $392.67K.
- Lineage Cell Therapeutics, Inc. proceeds from grantors for fiscal 2012 was $392.67K, a 75.00% decline from fiscal 2011.
- Lineage Cell Therapeutics, Inc. proceeds from grantors for fiscal 2011 was $1.57M.
| Period end | Proceeds from Grantors 3 month | Proceeds from Grantors 6 month | Proceeds from Grantors 12 month |
|---|---|---|---|
| 2012-12-31 | $261.78K 10-K · filed 2013-03-18 | $392.67K 10-K · filed 2013-03-18 | |
| 2012-06-30 | $392.67K 10-Q · filed 2012-08-09 | $785.33K 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $1.57M 10-K · filed 2013-03-18 | ||
| 2011-06-30 | $392.67K 10-Q · filed 2012-08-09 | $785.33K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |